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Transmembrane AMPA receptor regulatory proteins
(TARPs) and cornichon proteins (CNIH-2/3) indepen-
dently modulate AMPA receptor trafficking and
gating. However, the potential for interactions of
these subunits within an AMPA receptor complex is
unknown. Here, we find that TARPs g-4, g-7, and
g-8, but not g-2, g-3, or g-5, cause AMPA receptors
to ‘‘resensitize’’ upon continued glutamate applica-
tion. With g-8, resensitization occurs with all GluA
subunit combinations; however, g-8-containing
hippocampal neurons do not display resensitization.
In recombinant systems, CNIH-2 abrogates g-8-
mediated resensitization and modifies AMPA
receptor pharmacology and gating to match that of
hippocampal neurons. In hippocampus, g-8 and
CNIH-2 associate in postsynaptic densities and
CNIH-2 protein levels are markedly diminished in
g-8 knockout mice. Manipulating neuronal CNIH-2
levels modulates the electrophysiological properties
of extrasynaptic and synaptic g-8-containing AMPA
receptors. Thus, g-8 and CNIH-2 functionally interact
with common hippocampal AMPA receptor com-
plexes to modulate synergistically kinetics and phar-
macology.
INTRODUCTION
AMPA receptors are glutamate-gated ion channels that trans-
duce most fast excitatory synaptic transmission in mammalian
brain. These receptors mediate neuron-to-neuron signaling
that controls reflexes, behavior, and cognition. The synaptic
plasticity that underlies learning and memory often involves
activity-dependent recruitment of synaptic AMPA receptors
(Kandel, 2001; Malinow et al., 2000; Nicoll and Malenka, 1999).
Furthermore, dysregulation of AMPA receptors has been impli-
cated in numerous neurodegenerative and psychiatric disorders
(Lipton and Rosenberg, 1994).
AMPA receptors comprise homo- and hetero-tetramers of the
principal pore forming subunits GluA1-4 (Collingridge et al.,1082 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc2009; Dingledine et al., 1999; Hollmann and Heinemann, 1994;
Mayer and Armstrong, 2004; Seeburg, 1993). Transmembrane
regulatory AMPA receptor proteins (TARPs) are obligatory auxil-
iary subunits for many, if not all, neuronal and glial AMPA
receptor complexes (Cho et al., 2007; Coombs and Cull-Candy,
2009; Nicoll et al., 2006; Osten and Stern-Bach, 2006; Ziff, 2007).
TARP subunits regulate AMPA receptor protein biogenesis, traf-
ficking and stability, and also control channel pharmacology and
gating. Six transmembrane AMPA receptor regulatory protein
(TARP) isoforms, classified as Type I (g-2, -3, -4, and -8) and
Type II (g-5 and -7), are discretely expressed in specific neuronal
and glial populations and differentially regulate synaptic trans-
mission throughout the brain (Cho et al., 2007; Fukaya et al.,
2005; Kato et al., 2007, 2008; Milstein et al., 2007; Moss et al.,
2003; Soto et al., 2009; Tomita et al., 2003).
Key insights regarding the essential roles for TARPs derive
from studies of mutant mice. Cerebellar granule cells from star-
gazer mice, which have a null mutation in g-2, are deficient in
functional AMPA receptors (Chen et al., 2000; Hashimoto
et al., 1999). In g-8 knockout mice, hippocampal AMPA recep-
tors do not progress through the secretory pathway and do not
efficiently traffic to dendrites (Fukaya et al., 2006; Rouach
et al., 2005). In g-4 knockout mice, striatal mEPSC kinetics are
faster than those found in wild-type mice (Milstein et al., 2007).
Taken together, these genetic studies suggest that TARP
subunits associate with newly synthesized principal AMPA
receptor subunits, mediate their surface trafficking, cluster
them at synaptic sites, and regulate their gating.
Proteomic analyses have identified CNIH proteins as addi-
tional AMPA receptor auxiliary subunits (Schwenk et al., 2009).
These studies also show that CNIH-2 and 3 increase AMPA
receptor surface expression and slow channel deactivation
and desensitization. Also, CNIH-2/3 are found at postsynaptic
densities of CA1 hippocampal neurons and are incorporated
into70%of neuronal AMPA receptors. Yet, based on biochem-
ical analyses, Schwenk et al. (2009) proposed that TARPs and
CNIH-2/3 associate predominantly with independent AMPA
receptor pools.
Here, we investigated possible modulatory actions of TARP
and CNIH proteins at the same AMPA receptor complex. We
find that transfection of TARPs (g-4, g-7, or g-8) causes AMPA
receptors to resensitize upon continued glutamate application.
g-8-containing hippocampal AMPA receptors, however, do
not display resensitization suggesting that an endogenous.
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CNIH-2 and TARPs Modulate AMPA Receptorsregulatory mechanism prevents this. We find that coexpression
with CNIH-2—but not CNIH-1—abolishes g-8-mediated resen-
sitization. g-8 and CNIH-2 cofractionate and coimmunopre-
cipitate in hippocampal extracts while also colocalizing at
hippocampal synapses. Furthermore, genetic disruption of g-8
markedly and selectively reduces CNIH-2 and GluA protein
levels, indicative of a tripartite protein complex. Recapitulating
hippocampal AMPA receptor gating and pharmacology in trans-
fected cells requires coexpression of GluA subunits with both
g-8 and CNIH-2. In hippocampal neurons, overexpressing g-8
promotes resensitization and altering CNIH-2 levels modulates
synaptic AMPA receptor gating and extra-synaptic pharma-
cology. In cerebellar granule neurons from stargazer mice,
CNIH-2 transfection alone does not rescue synaptic responses
but, when dually expressed, CNIH-2 synergizes with g-8 to
enhance transmission. Together, these findings demonstrate
that hippocampal AMPA receptor complexes are controlled by
both CNIH-2 and g-8 subunits.
RESULTS
TARPs g-4, g-7, and g-8 Impart Resensitization Kinetics
upon AMPA Receptors
Previous studies in heterologous cells showed that cotransfec-
tion of g-7 with GluA1 or GluA2 creates AMPA receptor
complexes that, upon prolonged glutamate application, show
unexpected desensitization kinetics that are quite different
than kinetics from GluA subunits expressed either alone or
with g-2 (Kato et al., 2007, 2008). Here, we find that g-8 transfec-
tion imparts GluA1 with a similar kinetic signature, characterized
by glutamate-induced channel opening, rapid but incomplete
desensitization, followed by an accumulation of current that
achieves a large steady-state level (Figure 1A). We designate
this reversal of desensitization as ‘‘resensitization’’ and quantify
this as the fraction of steady-state current that accrues from the
trough of the initial desensitization (Figure 1A). For GluA1 coex-
pressed with g-8, resensitization accounts for 60% of the
steady-state current and develops with a t of 2.95 s (Figures
1A, 1C, and 1D). The extent of resensitization is independent of
glutamate-evoked current amplitude and extracellular calcium
(Figure 1E; see Figure S1 available online).
Resensitization shows remarkable TARP-dependent speci-
ficity. This phenomenon is not seen in receptors composed of
GluA1 alone or GluA1 containing g-2, g-3, or g-5 (Figures 1B
and 1D). By contrast, resensitization is evident when GluA1 is
coexpressed with g-4, g-7, or g-8. Resensitization accounts
for 35% of the steady-state current for g-4-containing recep-
tors, and fully 80% for g-7 containing receptors (Figures 1B
and 1D). Channel resensitization is qualitatively similar when
g-8 is coexpressed with each GluA1-4 subunit and also when
g-8 is coexpressed with heteromeric GluA1/2 receptors (Fig-
ure 1C). Comparison of the kinetics of resensitization between
subunits shows that GluA2-containing receptors resensitize
more slowly than GluA2-lacking receptors. In addition, differ-
ences in resensitization kinetics can be observed between
AMPA receptors expressing flip (i) or flop (o) splice variants;
g-8-containing GluA1/2o receptors resensitize more rapidly
than do g-8 containing GluA1/2i receptors (Figure 1C). Thus,Neresensitization is unique to g-4, -7, and -8 and appears to occur
with all GluA subunit combinations.
This kinetic phenotype could result from mechanisms unre-
lated to an apparent ‘‘reversal’’ of desensitization. To evaluate
these possibilities, we first performed experiments in the pres-
ence of cyclothiazide (CTZ), which blocks desensitization of all
GluA-flip isoforms. Results showed that CTZ abolished the de-
layed current run up in GluA1 receptors conferred by coexpres-
sion of g-8, suggesting that this phenomenon reflects a reversal
in desensitization (Figures 2A and 2C). Further confirmation
came from studies examining the effects of g-8 on the mutant
GluA1L497Y receptor, which does not show glutamate-evoked
desensitization (Stern-Bach et al., 1998). Consistent with the
results found with CTZ, g-8 expression did not produce the de-
layed increase in current when coexpressed with GluA1L497Y
(Figures 2B and 2C). As previously published for g-2 (Tomita
et al., 2007b), g-8 transfection did not significantly enhance
glutamate-evoked currents from GluA1L497Y (Figure 2E). On the
other hand, g-8 increased the ratio of kainate/glutamate-evoked
currents from GluA1L497Y, confirming association of g-8 with this
nondesensitizing receptor mutant (Figures 2D and 2F). These
data show that the g-8-mediated resensitization reflects reversal
of desensitization in AMPA receptors.
TARPs have a four transmembrane domain core and a cyto-
plasmic C-terminal tail, and alignment of the six TARP isoforms
does not show unique homologies among g-4, g-7, and g-8.
To investigate which domainsmediate resensitization, we gener-
ated three pairs of reciprocal chimeras that replaced in g-2 and
g-8 the partner’s N terminus through second transmembrane
domain (NT-TM2), the third through fourth TM domain (TM3-
TM4) and C-terminal domain, respectively. When cotransfected
with GluA1, these six chimeras interacted with and produced
functional AMPA receptors with large kainate-evoked currents,
indicating coexpression of functional TARP proteins (Figure S2).
Exchange of the C-terminal domains did not influence resensiti-
zation for g-8 or g-2 (Figure S2, V-VI), whereas both the NT-TM2
and TM3-TM4 chimeras showed no resensitization for either the
g-8 or g-2 host protein (Figure S2, I-II and III-IV, respectively).
Thus, these results indicate that resensitization requires noncon-
tinuous regions within the body of g-8.
Hippocampal AMPA Receptors Do Not Exhibit
Resensitization
Genetic studies have established that most AMPA receptor
complexes in hippocampal neurons contain g-8 (Fukaya et al.,
2006; Rouach et al., 2005). Consistent with previous studies,
GYKI 53784-sensitive, hippocampal AMPA receptors showed
no evidence of resensitization in response to glutamate (Figures
3A and 3C). Because AMPA receptors in g-8 knockout mice
have been shown to associate with g-2 (Menuz et al., 2009;
Rouach et al., 2005), the possibility exists that g-2 containing
AMPA receptors, which do not display resensitization, might
mask resensitization of hippocampal receptors. To test this
hypothesis, we recorded glutamate-evoked currents from
acutely isolated pyramidal neurons isolated from stargazer
mice, which are deficient in the g-2 subunit. We observed that
glutamate-evoked currents from hippocampal AMPA receptors
from stargazer mice also did not display resensitization anduron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc. 1083
Figure 1. AMPA Receptors Coexpressed with g-4, g-7, or g-8 Show Resensitization
(A) Representative trace of glutamate-evoked current in a HEK293T cell cotransfected with GluA1 and g-8. Glutamate-evoked current rapidly desensitizes and
then gradually resensitizes (IGlu-Resens), until reaching steady-state (IGlu-SS). Resensitization time course fits to a single exponential curve (red line).
(B) TARPs g-4, g-7, and g-8, but not g-2, g-3, or g-5 impart resensitization to GluA1.
(C) Glutamate-evoked currents with GluA1-4 subunit homomers and GluA1/2 heteromers coexpressed with g-8 show resensitization. Philanthotoxin was added
to isolate the currents mediated by GluA1 + GluA2-flop + g-8 from those by GluA1 + g-8. Note that the time constants for resensitization (t) depend upon GluA
subunits and TARPs.
(D) g-4, -7, and -8 exhibit resensitization.
(E) Resensitization does not depend on the size of the elicited steady state current. Numbers of repetitions are indicated above the bar graphs. Summary data are
mean ± standard error of the mean (SEM). See also Figure S1.
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Figure 2. Blocking Desensitization Occludes g-8-Mediated Resensitization
(A) Representative traces of glutamate-evoked currents from GluA1 and GluA1 + g-8 in the presence of CTZ, which blocks desensitization.
(B) Typical traces of glutamate-evoked currents from the nondesensitizing mutant GluA1L497Y with or without g-8. Resensitization percentage is
IGlu-Resens/IGlu-max.
(C) CTZ or the L497Y mutation abolishes resensitization even in the presence of g-8.
(D) The ratio of kainate/glutamate-evoked currents confirms g-8 incorporation.
(E and F) Steady state current levels elicited by glutamate (E) and kainate (F). Summary data are mean ± SEM. See also Figure S2.
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hippocampal neurons (Figures 3B–3D). These results indicate
that g-2 expression is not responsible for the absence of resensi-
tization in g-8 containing AMPA receptors.
CNIH-2 Specifically Blocks g-8 Mediated
Resensitization
Recently, CNIH-2/3 was shown to modulate AMPA receptor
pharmacology and kinetics (Schwenk et al., 2009). Because
CNIH-2 is expressed in the hippocampus (Schwenk et al.,
2009), we investigated the extent to which CNIH-2 could alter
g-8 induced resensitization and AMPA receptor pharmacology.
Fitting with previous studies, we found that CNIH-2 increases
the magnitude of currents evoked by glutamate (Figure S3A).
By generating chimeric constructs composed of CNIH-2 and
CNIH-1, a CNIH-2 homolog that does not functionally modulate
AMPA receptors, we found that first extracellular domain of
CNIH-2 plays a key role to enhance glutamate-evoked
currents (Figure S3B). In addition, we found that CNIH-2, like
TARPs, converts CNQX from an antagonist to a partial agonist,Nealbeit more weakly (Figure S3D) (Menuz et al., 2007). We
observed that transfection of CNIH-2 alone with GluA1 neither
promoted resensitization nor increased the ratio of kainate/
glutamate-evoked currents. However, coexpression of CNIH-2
with g-8 completely suppressed g-8 mediated resensitization,
while maintaining a high kainate/glutamate ratio (Figures 4A–
4C). Evaluation of the CNIH-1/2 chimeras revealed that the first
extracellular domain of CNIH-2 is necessary for CNIH-2 to
block g-8-mediated resensitization (Figure S3C). We explored
further the mechanism for CNIH-2 modulation of g-8-containing
receptors by employing a tandem construct, which links GluA1
to g-8 (Morimoto-Tomita et al., 2009; Shi et al., 2009). Expres-
sion of this GluA1/g-8 tandem yielded glutamate-evoked
currents that showed resensitization characteristic of g-8
containing AMPA receptors (Figure S3E). Cotransfecting
CNIH-2 with this tandem largely, but not completely, reversed
this resensitization and maintained a high kainate/glutamate
ratio (Figure S3E). These data demonstrate that g-8 and
CNIH-2 can simultaneously interact with a single AMPA
receptor complex.uron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc. 1085
Figure 3. AMPA Receptor-Mediated Res-
ponses from Hippocampal Pyramidal
Neurons Show No Resensitization
(A and B) Typical traces recorded from acutely iso-
lated hippocampal neurons from (A) wild-type
(+/+) and (B) stargazer mice (stg/stg). Responses
are blocked by a selective AMPA receptor antag-
onist, GYKI 53784 (20 mM).
(C) Resensitization percentages from wild-type
and stargazer acutely isolated hippocampal
neurons.
(D) Kainate- to glutamate-evoked current ratios in
wild-type and stargazer are similar. Summary data
are mean ± SEM.
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GluA1o/2 receptors, which predominate in hippocampal
neurons (Geiger et al., 1995). CNIH-2 alone did not induce
resensitization or alter the kainate/glutamate ratio of GluA1o/2
heteromers. Similar to GluA1 homomers, CNIH-2 coexpression
abolished g-8 mediated resensitization while maintaining
TARP-dependent, hippocampal neuronal-like increased kai-
nate/glutamate current ratios (Figure 3D and Figures 4D–4F).
Furthermore, reducing the amount of CNIH-2 cotransfection by
50%also inhibited g-8-mediated resensitization and did not alter
kainate/glutamate current ratios (Figures 4E and 4F).
We next evaluated the specificity of CNIH-2 suppression for
g-8-mediated resensitization. Previous studies showed that
LY404187 induces triphasic kinetics on AMPA receptors that
qualitatively resemble TARP-mediated resensitization (Quirk
et al., 2004). Indeed, we found that LY404187 conferred 60%
resensitization on GluA1o/2 expressing cells. Importantly,
LY404187-induced resensitization was not affected by cotrans-
fection with CNIH-2, indicating that the effects of CNIH-2 on
AMPA receptor resensitization are g-8 dependent (Figure S3F).
g-8 and CNIH-2 Colocalize and Cofractionate in
Hippocampus
To determine whether CNIH-2 and TARPs interact in hippo-
campal neurons, we generated antibodies to CNIH-2. By immu-
noblotting, our CNIH-2 antibody is specific and selectively inter-
acts with a 15 kD band in hippocampal extracts that
comigrates on SDS-PAGE with CNIH-2 expressed in heterolo-
gous cells (Figure 5A). This protein band is present in brain but
not in our survey of peripheral tissues (Figure 5B). CNIH-2 protein
is expressed at highest levels in the hippocampus, intermediate
levels in the cerebral cortex, striatum olfactory bulb, and thal-
amus and lower levels in the cerebellum consistent with its
mRNA distribution (Figure 5C) (Lein et al., 2007). Subcellular
fractionation of brain extracts revealed enrichment of CNIH-2
in microsomal and synaptosomal fractions, particularly within
the PSD. This distribution resembled that of g-8 and GluA1.
PSD-95 also was enriched in PSD fractions, and synaptophysin1086 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc.was absent from the PSD (Figure 5D).
Incubation of hippocampal slices with
a membrane-impermeant biotinylation
reagent detects CNIH-2 and GluA1 on
cell surface (Figure S4). Immunofluores-cent staining of hippocampal cultures showed punctate labeling
for CNIH-2 along dendrites and dendritic spines, where CNIH-2
colocalized with both TARPs and GluA1 (Figures 5E and 5F).
CNIH-2 also localized to dendritic puncta not containing GluA1
or TARPs.
We evaluated in vivo association of CNIH-2 and TARPs by
coimmunoprecipitation. Solubilized extracts of hippocampus
were incubated with pan-TARP antibodies and adherent
complexes were captured on protein A-coupled beads. Immu-
noblotting showed that CNIH-2 coprecipitated with TARPs and
GluA1. As controls, we found that kainate receptor isoforms
GluK2/3 were not present in this complex and that this protein
complex did not coimmunoprecipitate with pre-immune IgG
(Figure 5G). Subunits of a protein complex are often destabilized
when other components are genetically deleted, so we analyzed
CNIH-2 in g-8 knockout mice. As previously published (Rouach
et al., 2005), GluA1 and GluA2 levels are decreased by 60%–
70% in hippocampal of g-8 knockout mice (Figure 5H). Strik-
ingly, we found that CNIH-2 levels were reduced by >80% in
hippocampus from g-8 knockouts. Of note, we did not observe
any changes in the protein levels of kainate or NMDA receptor
subunits nor in postsynaptic proteins, PICK-1 and PSD-95 (Fig-
ure 5H). Together, these data imply that CNIH-2 is a component
of g-8 containing hippocampal AMPA receptors.
g-8 Expression Can Induce Resensitization in
Hippocampal Neurons
The absence of resensitization in hippocampal AMPA receptors
suggests that CNIH-2 maymodulate g-8 containing receptors or
that g-8 induced resensitization is somehow not possible in
neurons. To distinguish between these possibilities, we trans-
fected primary hippocampal cultures with g-8. Untransfected
neurons did not display glutamate-evoked resensitization.
However, resensitization was clearly evident in g-8 transfected
neurons (Figure 6A and 6B). The kainate/glutamate ratios in
g-8 transfected neurons were similar to the values detected in
nonneuronal cells containing GluA1o/2 and g-8 subunits (Fig-
ure 4F and Figure 6C). As in recombinant systems, CNIH-2
Figure 4. CNIH-2 Blocks g-8-Mediated Resensitization
(A1-4) Representative traces of glutamate- and kainate-evoked responses recorded from recombinant cells expressing GluA1 alone or with g-8 and/or CNIH-2 as
indicated. Note that CNIH-2 blocks g-8 mediated resensitization.
(B) Resensitization percentages from GluA1 receptor combinations.
(C) Kainate- to glutamate-evokedcurrent ratios (IKA/IGlu) fromGluA1 receptor combinations.Note thatCNIH-2 has little effect on (IKA/IGlu) withGluA1orGluA1+g-8.
(D1-5) Representative traces of glutamate- and kainate-evoked responses recorded from recombinant cells expressing GluA1o/2 heteromeric receptors either
alone with either g-8 and/or CNIH-2.
(E) Resensitization percentages from various GluA1o/2 receptor combinations. Note that CNIH-2 blocks g-8 mediated resensitization in heteromeric GluA1o/2
receptors.
(F) CNIH-2 has minimal effects on (IKA/IGlu) from GluA1o/GluA2 receptors. (E, F) Note that a 50% reduction in the amount of CNIH-2 transfected relative to GluA
subunit does not affect inhibition of resensitization or kainate/glutamate current ratios. Summary data are mean ± SEM. See also Figure S3.
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Figure 5. CNIH-2 and g-8 Interact within
a Hippocampal AMPA Receptor Complex
(A) Immunoblot of mouse hippocampal (Hp)
lysates reveals that the CNIH-2 antibody detects
a single band of 15 kD that comigrates with
CNIH-2 from transfected HEK cells.
(B) Immunoblot shows that CNIH-2 is enriched in
brain and not detectable in several peripheral
tissues.
(C) Brain regional immunoblot reveals that CNIH-2
is particularly enriched in the hippocampus (Hp)
with intermediate expression levels in the cerebral
cortex (Ctx), olfactory bulb (OB), striatum (Str), and
thalamus (Tha) and lower levels within the cere-
bellum (Crb). CNIH-2 was not detectable in brain
stem (BS) or spinal cord (SC).
(D) Subcellular fractionation shows enrichment of
CNIH-2 in the synaptosomal (Syn) andmicrosomal
(P3) fractions with a noticeable concentration in
PSD fractions. This distribution generally resem-
bles that of g-8 and GluA1. PSD-95 and synapto-
physin (Syp) serve as controls.
(E and F) Immunocytochemistry reveals colocali-
zation of CNIH-2, GluA1 (E) and TARPs (F) in the
dendrites and dendritic spines of cultured hippo-
campal neurons. Boxes denote from where the
zoomed images were taken.
(G) Immunoprecipitation analysis shows that
TARP complexes in hippocampus contain CNIH-2
and GluA1. As a control, GluK2/3 was absent from
the TARP complex.
(H) Western blots on hippocampal extracts from
four wild-type and four g-8 knockout mice reveal
a large reduction of CNIH-2 and GluA subunits in
the mutant. Knockout of g-8 did not affect protein
levels of kainate receptor subunits GluK2/3,
NMDA receptor subunit NR1, PSD-95, or PICK1.
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resensitization (Figure S5). These data indicate that resensitiza-
tion can occur in neurons and suggests a balance exists1088 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc.between g-8 and CNIH-2 in hippocampal
neuronal AMPA receptors to modulate
channel function.
Both CNIH-2 and g-8 Modulate
Synaptic AMPA Receptor Gating
We used fast perfusion electrophysiology
(trise < 1ms) to evaluate if g-8 and CNIH-2
synergistically modulate AMPA receptor
kinetics. Similar to previous reports,
GluA1 subunit expressed alone exhibits
fast kinetics (Figure 7A and 7B), and co-
expression of g-8 slowed deactivation
and desensitization rates (Cho et al.,
2007; Milstein et al., 2007). CNIH-2
expression slowed deactivation/desensi-
tization rates to a greater degree than
g-8, which is analogous to a previous
study comparing g-2 and CNIH-2/3
(Schwenk et al., 2009). Of note, coex-pression of CNIH-2 with g-8 further slowed deactivation/desen-
sitization rates (Figures 7A and 7B). Furthermore, analyses of
currents resulting from 1 ms and 200 ms glutamate applications
Figure 6. Overexpression of g-8 Induces
Resensitization in Hippocampal Pyramidal
Neurons
(A1–2) Representative traces of glutamate- and kai-
nate-evoked responses from untransfected and
g-8 transfected cultured hippocampal neurons.
AMPA receptor mediated currents were recorded
with 10 mMCPP, 10 mMbicuculline, 1 mMTTX, and
300 nM kynurenic acid.
(B) Quantification of resensitization.
(C) Kainate/glutamate ratios from untransfected
and g-8 transfected cultured hippocampal
neurons. Summary data are mean ± SEM. *p <
0.05. See also Figure S5.
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charge transfer than expression of either CNIH-2 or g-8 alone
(Figures 7A and 7B). To assess the role for endogenous CNIH-
2 in hippocampal synaptic function, we sought to knockdown
its expression using shRNA and, then, measure pharmacologi-
cally isolated, AMPA receptor-mediated miniature excitatory
postsynaptic responses (mEPSCs). This shRNA approach
reduced, but did not eliminate, CNIH-2 protein expression in
transfected HEK293T cells and cultured hippocampal neurons
(Figures S6A–S6C). Furthermore, CNIH-2 knockdown signifi-
cantly reduced hippocampal mEPSC charge transfer (Fig-
ure S6D) with no effect on rise time (untransfected: 1.0 ± 0.2
versus CNIH-2 shRNA: 1.0 ± 0.3 ms) or frequency (untrans-
fected: 4.4 ± 0.6 versus CNIH-2 shRNA: 3.1 ± 0.5 Hz).
To more directly measure CNIH-2 effects on extra-synaptic
and synaptic AMPA receptors, we utilized cultured stargazer
cerebellar granule neurons, which lack functional AMPA recep-
tors as well as TARP (Chen et al., 2000) and CNIH-2/3 subunits
(Schwenk et al., 2009). Similar to our heterologous cell findings
(Figure 4), bath application of glutamate to g-8-transfected star-
gazer granule cells produced a resensitizing current that was
inhibited by coexpression of CNIH-2 (Figure 7C). Transfection
of CNIH-2 alone did not rescue synaptic AMPA receptors
whereas transfection with g-8 produced mEPSCs that decayed
with a t of 2.5 ms (Figure 7D). Importantly, coexpression of
CNIH-2 with g-8 slowed mEPSCs (t4 ms) and did not have
significant effects on amplitude relative to wild-type or g-8-trans-
fected stargazer granule cells (Figure 7D). Taken together, these
results show that CNIH-2 can modulate decay kinetics of
synaptic AMPA receptors through synergic actions with g-8-
containing receptors.
Both g-8 and CNIH-2 Regulate Extra-Synaptic
Hippocampal AMPA Receptor Function
We next evaluated for CNIH-2 modulation of cyclothiazide (CTZ)
actions on kainate-evoked currents (IKA) from AMPA receptors,
for which the hippocampal neuronal phenotype has yet to be
recapitulated with coexpression of GluA and TARP subunits.
Previous studies found that CTZ potentiates kainate-evoked
currents 2-fold in hippocampal neurons (Patneau et al.,
1993), whereas in oocytes injected with GluA1 + g-8, CTZ
augments kainate-evoked currents by only 40% (Tomita
et al., 2007a). In the present studies, CTZ minimally potentiated
kainate-evoked currents from GluA1o/2 + g-8 (Figures 8A5 andNe8B). By contrast, CTZ potentiation of kainate-evoked currents
for GluA1o/2 alone was 12-fold (Figures 8A1 and 8B), which
was not significantly different from CTZ-potentiated kainate-
evoked currents from GluA1o/2 + CNIH-2 (7-fold). Importantly,
coexpression of CNIH-2 with g-8 modulated GluA1o/2 receptors
to yield CTZ potentiation of kainate currents of 2-fold, which
was quantitatively similar to that observed in acutely isolated
hippocampal neurons (Figures 8A3, 8A6, and 8B). The effect of
CNIH-2 on CTZ-mediated potentiation of kainate-evoked
currents was sensitive to a 50% reduction in the amount of
CNIH-2 transfected, which minimized the potentiation of kainate
currents to near g-8 alone levels (Figure 8A4). These data
suggest that CNIH-2 stoichiometry in AMPA receptors may
modulate CTZ pharmacology (Figure 8B). Furthermore, this
requirement for both g-8 and CNIH-2 to produce hippocampal
AMPA receptor-like kainate/CTZ pharmacology was also
observed for transfections with GluA1i/GluA2 heteromeric
receptors (Figure S7).
Cultured hippocampal neurons transfected with CNIH-2
shRNA exhibited reduced CTZ potentiation of IKA (Figure 8B).
CNIH-2 knockdown also produced resensitization in only one
out of nine hippocampal neurons (data not shown), supporting
the hypothesis that complete elimination of CNIH-2 expression
is necessary to reveal g-8-mediated resensitization, whereas
a graded stoichiometric mechanism likely explains the effect of
CNIH-2 on kainate/CTZ pharmacology. Collectively, these
results indicate that g-8 and CNIH-2 are required to recapitulate
native hippocampal AMPA receptor complexes.
DISCUSSION
The present studies demonstrate that TARP isoforms g-4, g-7,
and g-8 can impart a unique resensitization signature upon
AMPA receptors. This resensitization is characterized by a de-
layed accumulation of current flux upon continued application
of glutamate. The absence of resensitization in CA1 hippo-
campal neurons, whose AMPA receptor complexes predomi-
nantly contain g-8, indicates that additional proteins regulate
hippocampal AMPA receptors. Indeed, we find that CNIH-2
specifically blocks resensitization of g-8-containing AMPA
receptors. Also, reconstitution of hippocampal kainate/CTZ
pharmacology requires interaction between g-8 and CNIH-2.
Whereas CNIH-2 alone cannot traffic AMPA receptors to
synapses of stargazer granule neurons, CNIH-2 synergizesuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc. 1089
Figure 7. Synaptic AMPA Receptor Complexes Are Modulated by both CNIH-2 and g-8
(A1 and B1) Scaled representative traces of 200ms (desensitization, A1) and 1ms (deactivation, B1) glutamate-evoked responses onto recombinant cells express-
ing GluA1 alone or with g-8, and/or CNIH-2 as indicated.
(A2 and B2) Calculated weighted tau of desensitization (A) or deactivation (B) fit with a bi-exponential function.
(A3 and B3) Calculated charge transfer from 200 ms (A) and 1 ms (B) glutamate application onto recombinant cells expressing GluA1 alone or with g-8, and/or
CNIH-2 as indicated. *p < 0.05 when compared to GluA1. #p < 0.05 when compared to g-8.
(C1–C3) Representative traces (C1), quantified resensitization (C2), and steady-state current (C3) after glutamate application to wild-type (+/+) or transfected star-
gazer (stg/stg) cerebellar granule neurons. Currents evoked from g-8 transfectants show resensitization and this is prevented by cotransfectionwith CNIH-2. Note
that CNIH-2 alone restored glutamate-evoked currents in 3 of 10 transfected neurons.
(D1–D3) Synaptic AMPA receptor-mediated mEPSCs were recorded from cultured cerebellar granule neurons from wild-type or stargazer mice transfected with
CNIH-2 and/or g-8. (D1) CNIH-2 synergizes with g-8 to slow AMPA-receptor mEPSC decay constant (D2) without affecting mEPSC amplitude (D3) in transfected
cerebellar granular neurons. Note the absence of synaptic AMPA receptor responses in stargazer neurons transfected with CNIH-2 alone (ND, not detectable).
*p < 0.05 when compared to +/+. #p < 0.05 when compared to stg/stg + g-8. Summary data are mean ± SEM. See also Figure S6.
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CNIH-2 and TARPs Modulate AMPA Receptorswith g-8 to control synaptic gating and charge transfer. Hippo-
campal CNIH-2 protein occurs as postsynaptic densities, asso-
ciates with g-8-containing AMPA receptors and relies on g-8
complexes for stability. Taken together, these data suggest
that both g-8 and CNIH-2 associate within a native hippocampal
AMPA receptor complex to control transmission.
AMPAReceptor Resensitization Is a Property of Specific
TARP Isoforms
The prototypical TARP, stargazin, was initially suggested to
serve primarily as a chaperone for AMPA receptor trafficking to
the cell surface and synapse (Chen et al., 2000). Subsequent
biophysical studies showed that TARPs also have profound
effects on AMPA receptor pharmacology and channel gating.
TARPs generally increase AMPA receptor affinity for glutamate
(Kott et al., 2007; Priel et al., 2005; Tomita et al., 2005) and1090 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Incnoncompetitive antagonists (Cokic and Stein, 2008), increase
the efficacy of kainate (Tomita et al., 2005; Tomita et al.,
2007a; Turetsky et al., 2005), and alter the pharmacology of
competitive antagonists (Kott et al., 2009; Menuz et al., 2007)
and CTZ-like potentiators (Tomita et al., 2006). The effects of
TARPs on AMPA receptor gating include slowing of AMPA
receptor deactivation and desensitization and augmentation of
glutamate-evoked steady-state currents (Bedoukian et al.,
2006; Priel et al., 2005; Turetsky et al., 2005). At the single
channel level, TARPs can increase open channel probability
and burst duration (Tomita et al., 2005). Through these effects,
TARPs typically augment charge transfer during synaptic
transmission.
Our studies identify AMPA receptor resensitization as a new
gating characteristic conferred by specific TARP isoforms.
Resensitization occurs only in AMPA receptors assembled with.
Figure 8. Recapitulation of Hippocampal AMPA Receptors Pharmacology Requires Both CNIH-2 and g-8
(A) Representative traces of kainate-evoked responses in the presence or absence of CTZ from (A1–5) recombinant cells, (A6) acutely isolated hippocampal (Hp)
neurons, or (A7–8) cultured hippocampal neurons.
(B) Quantification of CTZ potentiation of kainate-evoked responses. *p < 0.05 when compared to GluA1o/2 and #p < 0.05 when compared to untransfected
cultured hippocampal neurons. The dotted line represents themean CTZ-induced IKA potentiation observed in acutely isolated or cultured hippocampal neurons.
Note that a 50% reduction in the amount of CNIH-2 transfected relative to GluA subunit reduces CTZ potentiation of kainate-evoked currents, which is qualita-
tively similar to the effect of CNIH-2 shRNA transfection in cultured hippocampal neurons. Summary data are mean ± SEM. See also Figure S7.
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CNIH-2 and TARPs Modulate AMPA Receptorsg-4, g-7, and g-8. Whereas resensitization is qualitatively similar
with these three TARPs, the magnitude of resensitization is
greatest with g-7. The present studies demonstrate that g-8
can bestow resensitization on homomeric receptors of all GluA
subunits, as well as on heteromeric receptors. The magnitude
of resensitization is similar for homomeric receptors of each
GluA subunit, but develops more slowly with GluA2-containing
receptors and more rapidly with a receptor having a flop alterna-
tively-spliced GluA subunit.
The TARP-associated resensitization resembles the kinetics of
several positive allosteric modulators of AMPA receptors
including PEPA (Sekiguchi et al., 2002) and LY404187 (Quirk
et al., 2004). For LY404187, time-dependent enhancement in
modulation (resensitization) is evident in flip splice variants of ho-
momeric GluA1-4 receptors and depends on a single residue
(Ser754), in the flip/flop domain at the interface of adjacent GluA
subunits (Quirk et al., 2004; Sun et al., 2002). Structural studiesNeof the ligand-binding core of GluA receptors indicate that desen-
sitization involves weakening of the intermolecular interface
between dimeric GluA subunits (Sun et al., 2002). Interestingly,
exchange of Asp754 for Ser dramatically increases the rate and
extent of desensitization of GluA receptors (Partin et al., 1996)
and markedly destabilizes dimerization of the ligand-binding
core (Sun et al., 2002). Conversely, pharmacological manipula-
tions that attenuate GluA receptor desensitization, stabilize
dimerization of the glutamate ligand-binding modules at least in
part through interactions with Ser754 (Sun et al., 2002). Our data
suggest amodelwherebyg-4,g-7, andg-8 promoteGluA subunit
ligand-binding domain dimerization and thereby partially reverse
desensitization. Recent structural analysis of intact GluA2 indi-
cates that juxta-membrane regions alsomaymediate interactions
with auxiliary subunits (Sobolevsky et al., 2009). Future structural
studies of GluA with auxiliary subunits are needed to define the
molecular mechanism for receptor assembly.uron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc. 1091
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CNIH-2 and TARPs Modulate AMPA ReceptorsIt remains unclear why resensitization is induced specifically
by g-4, g-7, and g-8. Although the first extracellular domain of
TARPs mediates effects on receptor pharmacology and gating
(Bedoukian et al., 2006; Tomita et al., 2005), this region is not
specifically conserved between g-4, -7, and -8 and we find
that substituting this region from g-8 into g-2 does not induce re-
sensitization. In fact, none of our chimeras that replaced either
pairs of transmembrane domains or the C-terminal region
between g-2 and g-8 interchanged resensitization. Apparently,
resensitization requires interactions with discontinuous
segments within the 3D structures of g-8.
CNIH-2 Modulates g-8 Containing AMPA Receptors
Previous studies in heterologous cells showed that CNIH-2/3—
like type I TARPs—augment glutamate-evoked currents and
also slow receptor desensitization and deactivation (Schwenk
et al., 2009), which we confirmed. We also found that CNIH-2
more weakly mimics the effect of TARPs to convert CNQX
from an antagonist to a partial agonist. However, unlike type I
TARPs, we found that CNIH-2 did not increase the kainate/gluta-
mate ratio from these GluA receptors. These results indicate that
TARPs and CNIH-2 modulate AMPA receptors through distinct
mechanisms.
To assess for functional interactions, we transfected g-8 and
CNIH-2 together with various GluA constructs and found striking
results, which included blockade of g-8 mediated resensitiza-
tion. That CNIH-2 suppressed resensitization of a GluA1/g-8
tandem construct decisively shows that these two classes
of associated proteins can both interact with a common
AMPA receptor complex, and likely have distinct interaction
sites. Importantly, we found that CNIH-2 abolishes g-8-induced
resensitization but left intact the TARP-mediated augmenta-
tion of the kainate/glutamate ratio. This suppression of g-8-
mediated resensitization is specific, because we found that
CNIH-2 did not blunt pharmacological resensitization induced
by LY404187.
We found no effect on resensitization or the magnitude of
glutamate-evoked currents with CNIH-1, a homologous protein
expressed in peripheral tissues. Taking advantage of this isoform
specificity, we constructed a series of chimeras that inter-
changed regions in CNIH-2 and CNIH-1. This analysis identified
the proposed first extracellular loop of CNIH-2 as necessary for
modulation of AMPA receptor gating and blunting g-8-mediated
resensitization. This result is consistent with interaction of the
CNIH-2 extracellular domain with the GluA ligand binding core.
CNIH-2 and g-8 Interact with a Common AMPAReceptor
Complex
The biophysical properties of hippocampal AMPA receptors
appear to reflect an interaction between g-8 and CNIH-2 within
an AMPA receptor complex. Although most extra-synaptic
hippocampal AMPA receptors contain g-8 (Fukaya et al., 2006;
Rouach et al., 2005), we did not detect resensitization in CA1
pyramidal cells. Resensitization also was not observed in hippo-
campal AMPA receptors from stargazer mice, which depend
upon g-8 but not other TARPs for activity (Menuz et al., 2009;
Rouach et al., 2005). Conversely, resensitization was evident in
cells transfected with GluA1o/2 + g-8. Coexpression with1092 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier IncCNIH-2 eliminated the resensitization of GluA1o/2 + g-8 contain-
ing cells suggesting that CNIH-2 functionally interacts with g-8-
containing hippocampal AMPA receptors. This interaction
hypothesis is further supported by robust coimmunoprecipita-
tion of CNIH-2 TARP-containing AMPA receptors in hippo-
campus. Also, CNIH-2 cofractionates and colocalizes with
GluA and g-8 subunits in postsynaptic densities. Importantly,
CNIH-2 protein levels are dramatically reduced in hippocampus
of g-8 knockout mice. Together, these data strongly suggest that
CNIH-2 protein occurs within native g-8-containing AMPA
receptor complexes.
Further evidence for an interaction between g-8 and CNIH-2
derives from pharmacological analyses. While CTZ is known to
potentiate kainate-induced currents 2-fold in hippocampal
neurons (Patneau et al., 1993), negligible potentiation was
observed when g-8 alone was transfected with GluA1o/2 hetero-
meric receptors. By contrast, CTZ potentiates kainate-evoked
responses by 2-fold in GluA1o/2 heteromeric receptors co-
transfected with g-8 and CNIH-2. Partial knockdown of CNIH-2
in shRNA-transfected hippocampal neurons recapitulated the
reduced CTZ potentiation efficacy observed with g-8 transfec-
tion alone. Interestingly, resensitization was detected in only
one out of nine CNIH-2 shRNA-transfected hippocampal
neurons. These findings may suggest that more than one
CNIH-2 subunit associates with an AMPA receptor-TARP
complex and that CNIH-2 regulates neuronal KA/CTZ pharma-
cology in a graded fashion. Previous studies have shown the
number of TARPs per AMPA receptor complex could be variable
(Kim et al., 2010; Shi et al., 2009). Future studies are needed to
define the stoichiometry of both TARPs and CNIH-2 within native
AMPA receptor complexes.
Functional Implications of TARP and CNIH-2
Coregulation of Hippocampal AMPA Receptors
These studies provide important new insights regarding AMPA
receptor function. Whereas previous biochemical studies sug-
gested that TARPs and CNIH-2/3 interact predominantly with
independent pools of AMPA receptors, our results reveal crucial
cooperative interactions. CNIH-2 can promote surface expres-
sion of GluA subunits in transfected cells (Schwenk et al.,
2009), but this has not been definitively demonstrated in hippo-
campal neurons. The dramatic loss of extrasynaptic AMPA
receptors in g-8 knockout mice (Fukaya et al., 2006; Rouach
et al., 2005) suggests that CNIH-2 cannot efficiently traffic
AMPA receptors in these neurons. Of note, CNIH proteins lack
a synaptic-targeting PDZbinding site and, in this study, we found
that CNIH-2 could not rescue synaptic AMPA receptors in star-
gazer granule cells. While this work was under final review, Shi
et al. (2010) also found that CNIH-2 can partially restore extrasy-
naptic but not synaptic AMPA receptor function in cerebellar
granule cells from homozygous or heterozygous stargazer
mice. On the other hand, we find that CNIH-2 can synergize
with g-8 to augment synaptic AMPA receptor function in homo-
zygous stargazer cerebellar granule neurons. Thus, multiple
classes of auxiliary subunits acting on a common GluA tetramer
provide a combinatorial layer of complexity for regulation of
AMPA receptors in diverse cell types and physiological
conditions..
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CNIH-2 and TARPs Modulate AMPA ReceptorsPrevious studies showed that CNIH protein from both verte-
brates and invertebrates mediate endoplasmic reticulum (ER)
export of specific growth factors (Hoshino et al., 2007; Roth
et al., 1995). It is therefore possible that CNIH-2 transiently
interacts with g-8-containing AMPA receptor complex solely
within the ER to modulate function. Indeed, Shi et al. found
that overexpressed CNIH-2 accumulates in the Golgi apparatus
and does not occur on the neuronal surface (Shi et al., 2010).
However, our subcellular fractionation studies indicate that
endogenous CNIH-2 is enriched in synaptosomes and is partic-
ularly concentrated together with TARPs and AMPA receptors in
postsynaptic densities. In addition, electron microscopic data
reveal CNIH-2/3 immunoreactivity at postsynaptic sites in hippo-
campal CA1 neurons (Schwenk et al., 2009). Furthermore, our
characterization of neuronal AMPA receptor resensitization and
kainate/CTZ pharmacology, together with our analysis of
synaptic AMPA receptor gating in hippocampal and stargazer
cerebellar granule neurons, suggests that CNIH-2 associates
with synaptic and extra-synaptic g-8-containing AMPA recep-
tors. The dramatic (>80%) loss of hippocampal CNIH-2 protein
in g-8 knockout mice implies a fundamental connection between
CNIH-2 and g-8-containing AMPA receptor protein complexes.
Multiple classes of transmembrane subunits interacting within
a native glutamate receptor complex appears to be an evolution-
arily-conserved regulatory mechanism. Glutamate receptors
in C. elegans are controlled by interactions among two classes
of auxiliary subunits: suppressor of Lurcher (SOL)-1 and TARPs
(Wang et al., 2008). SOL-1 is a transmembrane CUB domain
protein, unrelated to CNIH (Zheng et al., 2004). However, another
CUB domain protein, Neto2 regulates mammalian kainate
receptor trafficking and gating (Zhang et al., 2009). In addition,
studies have found recently that another AMPA receptor
auxiliary subunit, CKAMP44, associates with AMPA receptors
and reduces currents (von Engelhardt et al., 2010).Multiple auxil-
iary subunits regulate trafficking and gating of voltage-gated
calcium channels, and the a2d subunit also controls the pharma-
cology of certain calcium channel compounds (Gee et al., 1996).
As AMPA receptor modulators show therapeutic potential in
numerous neuropsychiatric disorders (Kato and Bredt, 2007),
TARP and CNIH proteins provide intriguing pharmacological
targets.EXPERIMENTAL PROCEDURES
Materials
All salts, precast gels, and buffers were from Sigma Aldrich (St. Louis, MO),
Invitrogen (Carlsbad, CA), Fisher Scientific (Pittsburgh, PA), or Bio-Rad Labo-
ratories (Hercules, CA). Antagonist and agonists were from Tocris Bioscience
(Ellisville, MO). Polyclonal antibodies against GluK2/3 (04-921), pan-Type I
TARP (07-577), and GluA1 (AB1504) and monoclonal antibody against
GluR2 (MAB3397) were purchased fromMillipore (Billerica,MA). Mousemono-
clonal PSD-95 antibody (MA1-046) and polyclonal antibody against PICK-1
(PAI-073) were purchased from Affinity Bioreagents (Rockford, IL). Mouse
monoclonal synaptophysin antibody (S5768) was purchased from Sigma-Al-
drich (St. Louis, MO). Mouse monoclonal antibody against NR1 (556308)
was purchased from BD PharMingen (San Jose, CA). Affinity-purified poly-
clonal antibodies for CNIH-2 were generated by immunizing guinea pigs with
the following peptide sequence from human CNIH-2 protein, DELRTDFKN-
PIDQGNPARARERLKNIERIC. HRP-conjugated anti-guinea pig secondary
antibody (706-035-148) and HRP-conjugated native secondary antibody forNemouse- and rabbit-derived primary antibodies (21230) were from Jackson
Laboratories (West Grove, PA) and Fisher Scientific, respectively.
cDNA Cloning
All GluA cDNAs are flip splice variants unless indicated. All GluA and TARP
cDNAs were derived from human except for GluA2, which was cloned from
rat. shRNA producing plasmids and lentiviral particles were purchased from
Sigma-Aldrich. (#1: TRCN0000109842, #2: TRCN0000109844).
Recombinant Cell Culture and Transfection
HEK293T cells were maintained at 37C in 5% CO2 high glucose DMEM
medium supplemented with 10% fetal calf serum and 1% penicillin-strepto-
mycin and split bi- or triweekly. HEK293T cells were plated in 35 mm dishes
and were transiently transfected using FuGENE 6 according to manufacturer’s
protocols (11814443001: Roche Applied Sciences, Indianapolis, IN). GluA,
TARP and CNIH cDNAs were cotransfected with a GFP-expressing reporter
plasmid for identification in electrophysiology experiments. One hundred
percent CNIH-2 transfection indicates equal amounts of CNIH-2 and GluA
subunit cDNAs and 50% CNIH-2 reduces this ratio by one half. The cells
were trypsinized 1 day after transfection and plated on glass coverslips at
low density (5000/cm2). Experiments were performed 48–72 hr
posttransfection.
Primary Cerebellar Granule and Hippocampal Culture and
Transfection/Infection
Stargazer mice were obtained from Jackson Laboratory and maintained at the
Yale animal facility under the guidelines of the Institutional Animal Care and
Use Committee. Heterozygous male and female mice were mated to obtain
homozygous stargazer mice. Cerebellar granule cell cultures were prepared
from postnatal day 7–8 (P7–8) homozygous stargazer mice and were trans-
fected at 5 days in vitro (DIV5) as described (Cho et al., 2007). Primary cultures
of rat hippocampal neurons were prepared essentially as described (Kato
et al., 2008). Briefly, hippocampi dissected from E19 Wistar rat embryos
were incubated at 37C for 10 min in a papain solution (in mM): 5 L-cysteine,
1 ethylenediaminetetraacetic acid, 10 HEPES-NaOH (pH 7.4), 100 mg/ml
bovine serum albumin, 10 U/ml papain (Worthington), and 0.02% DNase
(Sigma). The reaction was stopped by addition of an equal volume of fetal
bovine serum. The cells were triturated and washed with Neurobasal (Invitro-
gen) supplemented with B-27, 100 mg/ml penicillin, 85 mg/ml streptomycin,
0.5 mM glutamine. The cells were plated on 12 mm coverslips coated with
poly-D-lysine in 24-well plates at 100,000 cells/well density. cDNA (g-8,
CNIH-2, or g-8 and CNIH-2)- or CNIH-2 shRNA-Lipofectamine 2000 (Invitro-
gen) complexes were prepared in Neurobasal medium according to manufac-
turer’s specifications. Primary neurons (>14 DIV) were incubated with these
Lipofectamine complexes in Neurobasal medium in the absence of B-27, peni-
cillin/streptomycin, and L-glutamine for at least 2 hr and then returned to the
original conditioned medium. Electrophysiological recordings from primary
neurons were performed at least 48 hr posttransfection. Lentiviral particles
for shRNAs were infected at multiplicity of infection = 2.
Acutely Isolated Neurons
Hippocampal pyramidal neurons from 5- to 8-month-oldmice were isolated as
previously described (Kato et al., 2008). Briefly, a rapidly dissected brain was
immersed in ice cold NaHCO3-bufferd saline solution (in mM): 120 NaCl, 2.5
KCl, 1 MgCl2, 1.25 Na2PO4, 2 CaCl2, 26 NaHCO3, and 10 glucose (pH 7.2),
osmolarity 300 ± 2 mOsm/l. Coronal hippocampal slices (400 mm thick) were
prepared by a Vibroslice (Campden Instruments) in ice cold NaHCO3-bufferd
saline solution and then were recovered at room temperature in continuously
oxygenated (95% O2, 5% CO2), NaHCO3-bufferd saline solution for 0.5–5 hr.
The slices were transferred to a petri dish containing low-Ca2+ HEPES buffered
saline (Low-Ca2+ HBS) (in mM): 140 sodium isothionate, 2 KCl, 4 MgCl2, 0.1
CaCl2, 15 HEPES (pH7.2), osmolarity 300 ± 2mOsm/l. Dissected hippocampal
CA1-CA3 regions were placed into a holding chamber containing protease
type XIV (1 mg/ml, Sigma-Aldrich) dissolved in oxygenated HEPES-buffered
Hank’s balanced salt solution (HBSS 6136: Sigma-Aldrich) and maintained
at 37C, pH 7.4, osmolarity 300 ± 5 mOsm/l. After 30 min incubation in the
enzyme solution, the tissue was rinsed three times with the Low-Ca2+ HBSuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Inc. 1093
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CNIH-2 and TARPs Modulate AMPA Receptorsand triturated using fire-polished Pasteur pipettes. The cell suspension was
placed into a 50 mm plastic petri dish for electrophysiological recordings.
Hippocampal pyramidal neurons were selected on the basis of their character-
istic morphology.Electrophysiology
Agonist-evoked currents were recorded from transfected HEK293T cells,
acutely isolated neurons, and primary hippocampal cultures as described
(Kato et al., 2008). Recordingsweremade using thick-walled borosilicate glass
electrodes pulled and fire-polished to a resistance of 2–5 MU. All cells were
voltage-clamped at 80 mV and data were collected and digitized using
Axoclamp 200 and Axopatch software and hardware (Molecular Devices,
Sunnyvale, CA). For whole cell recordings, the transfected HEK293T cells
were bathed in external solution containing the following (in mM): 117 TEA,
13 NaCl, 5 BaCl2, 1 MgCl2, 20 CsCl, 5 glucose, and 10 Na-HEPES pH 7.4 ±
0.03. For acutely isolated and cultured primary neurons, 10 mM CPP, 10 mM
bicuculline, 1 mM TTX, and 300 nM 7-chlorokynurenic acid were added in
the external solution and the extracellular concentration of NaCl was increased
to 130 mM and TEA was omitted. 7-Chlorokynurenic acid (7-CK) was omitted
for acutely isolated neurons. The intracellular electrode solution contained the
following (in mM): 160 N-methyl-D-glucamine, 4 MgCl2, 40.0 Na-HEPES
pH 7.4, 12 phosphocreatine, 2.0 Na2-ATP pH7.2 ± 0.02 adjusted by H2SO4.
For neuronal recordings, 1 mM QX314 were added to the internal solution.
For outside-out patches and whole cell recordings using fast perfusion, the
internal solution contained (in mM): 130 CsCl, 10 CsF, 10 Cs-HEPES pH 7.3,
10 ethylene glycol tetraacetic acid (EGTA), 1 MgCl2, and 0.5 CaCl2 and was
adjusted to 290 mOsm.
The transfected HEK293T cell or the acutely isolated neuron was lifted and
perfused with ligand-containing solutions from a sixteen-barrel glass capillary
pipette array positioned 100–200 mm from the cells (VitroCom). Each gravity-
driven perfusion barrel is connected to a syringe 30 cm above the recording
chamber. The solutions were switched by sliding the pipette array with an
exchange rate of less than 20ms. For fast application experiments with a junc-
tion potential rise time of less than 300 ms, rapid solution exchange (1 and
200 ms application for deactivation and desensitization, respectively) from
a q tube containing external solution (in mM: 140 NaCl, 3 KCl, 10 glucose,
10 HEPES pH 7.3, 2 CaCl2, 1 MgCl2) in one barrel and external solution
containing glutamate or kainate in the other barrel was driven by a piezo actu-
ator. Glutamate and kainate (1mM), CNQX (20 mM), and LY404187 (3 mM)were
applied where indicated and cyclothiazide (CTZ; 100 or 200 mM) was added to
the external for potentiation experiments. The recording from primary cultured
neurons was performed on the coverslips where the neurons had grown with
the 16-barrel pipette array positioned 200–500 mm away from the recorded
neurons. Unless otherwise indicated (Figure 2), resensitization percentage
was calculated as:
IGluResens=IGluSS 3 100;
where IGlu-Resens is the current that accrues from the trough of desensitization
(Figure 1A). Kainate/glutamate ratios were calculated as:
IKAss=IGluss;
where IKA-ss and IGlu-ss are the steady state responses evoked by kainate and
glutamate application, respectively. CTZ potentiation of kainate-evoked
responses was calculated as:
ððIKA +CTZ=IKA Þ3 100Þ  100;
where IKA + CTZ is the steady state current amplitude recorded during kainate +
CTZ application and IKA is the steady state current amplitude recorded during
kainate application.
Spontaneous AMPA receptor-mediated miniature excitatory postsynaptic
currents (mEPSC) from transfected and untransfected cultured primary hippo-
campal neurons (>14 DIV) were recorded in the presence of 10 mMbicuculline,
50 mM picotoxin, 10 mM CPP, 300 nM 7-CK, and 3 mM TTX using an internal
solution containing (in mM): 95 CsF, 25 CsCl, 10 Cs-HEPES pH 7.4, 10
EGTA, 2 NaCl, 1 MgCl2, 10 QX-314, and 5 TEA-Cl adjusted to 290 mOsm
with Mg-ATP. mEPSCs used for analysis were collected from a 2 min period1094 Neuron 68, 1082–1096, December 22, 2010 ª2010 Elsevier Incimmediately after a 3 min recording solution equilibrium period, were in-
spected visually and were selected with a lower limit amplitude cutoff of
greater than 15 pA to eliminate any possible contamination from noise and
holding current oscillation. Analyses and curve fitting were performed using
MiniAnal software (Synaptosoft, Decatur, GA).
Patch-clamp recordings from cerebellar granule cells (DIV7–10) were made
in external solution containing (in mM): 10 HEPES, 140 NaCl, 2.5 KCl,
2.5 CaCl2, 1.3 MgSO4, 2.7 MgCl2, and 10 glucose. Patch pipettes were filled
with recording solution (pH 7.2, 320mOsm) that contained (inmM): 130 cesium
methanesulfonate, 5 HEPES, 5 Mg-ATP, 0.2 Na-GTP, 20 TEA, and 5 EGTA. All
recordings were performed at room temperature. To isolate and record AMPA
receptor-mediated mEPSCs, tetrodotoxin (0.5 mM), AP-5 (50 mM), and
picrotoxin (100 mM) were added to the external solution. mEPSCs were
recorded from cerebellar granule cells in whole-cell configuration at a holding
potential of 70 mV. The current was analog low-pass filtered at 3 kHz and
digitally sampled at 25 kHz. Sampling traces were further filtered with
eight-pole low-pass Bessell filter (1 KHz, 3 dB) for demonstration purposes.
Amplitude and frequency of events were analyzed using Minianalysis (Synap-
tosoft). mEPSCs were fitted with bi-exponential functions to determine decay
kinetics (t).
Subcellular Fractionation
Subcellular fractionations were performed at 4C essentially as described
previously (Kato et al., 2008). From each centrifugation step, the supernatant
was reserved and each pellet was resuspended in buffer I and used in the
next centrifugation step. Ten rat forebrains were dissected and homogenized
on ice in 10ml of ice-cold buffer I (0.32M sucrose, 3mMHEPES supplemented
with 0.1 mg/mL PMSF, pH 7.4). The homogenate was centrifuged at 10003 g
for 10 min to yield pellet 1 (P1) and supernatant 1 (S1). Each from the following
centrifugation steps resulted in the appropriate supernatant and pellets:
12,0003 g for 15 min, 33,0003 g for 20 min, and 260,0003 g for 2 hr to yield
P2, P3, and P4 pellets, respectively. In a separate fractionation, ten rat fore-
brains were separated into synaptosomal fractions via use of a discontinuous
sucrose gradient. PSD fractions I and II were obtained by two serial extractions
of the synaptosomal fractions with 0.5% TX-100 in 6 mM Tris-HCl (pH 7.5) fol-
lowed by centrifugations of 100,000 3 g for 1 hr. For tissue and brain region
specific analyses, the P2 fraction was collected from each tissue and brain
region and separated via SDS-PAGE for expression comparison.
Coimmunoprecipitation and Immunoblotting
Coimmunoprecipitations were carried as described previously (Kato et al.,
2008). Briefly, ten rat hippocampi were homogenized in 10ml of ice-cold buffer
I and centrifuged for 20 min at 20,000 3 g at 4C. The resulting pellet was
resuspended in 4 vol (v/w) of buffer I and then solubilized at 4C with 1.0%
TX-100 for 1 hr with continuous mixing. After a 1 hr centrifugation at
100,0003 g, the supernatant was precleared with protein A-Sepharose beads
for 1 hr and then incubated with 5 mg of affinity purified rabbit anti-pan Type I
TARP for 2 hr at 4C. Then, the antibody/homogenate mixture was incubated
with 50 ml of protein A-Sepharose resin for 1 hr at 4C. The antibody/antigen
bound resin was then washed eight times with buffer I supplemented with
20 mM NaCl. Bound proteins were eluted with Laemmli buffer containing
5% SDS at 55C for 30 min followed by a 10 min incubation at 95C. Input
protein (0.5%) and 33% of each coimmunoprecipitation were separated via
SDS-PAGE and eluted proteins were detected via immunoblotting with appro-
priate antibodies: GluA1 (1:1000), pan-Type I TARP (1:1000), synaptophysin
(1:50), PSD-95 (1:100), g-8 (1:1000), CNIH-2 (1:1000), and GluK2/3 (1:500).
Coimmunoprecipitations of homogenates with 10 ml of pre-immune serum or
5 mg of control IgG served as controls.
Immunocytochemistry
Cultured primary hippocampal neurons (>17 DIV) were washed in Dulbecco’s
phosphate buffered saline (D-PBS) and fixed in 4% paraformaldehyde/4%
sucrose for 10 min. Immediately after, neurons were postfixed in ice cold
(20C) methanol for 10 min. Cultures were rinsed and then blocked and per-
meabilized in D-PBS including 0.1% Triton X-100 and 3% normal goat serum
for 1 hr at room temperature. Cultures were incubated overnight at 4C with
primary antibody (1:100, GluA1; 2.2 mg/mL, CNIH-2; 1:50, pan-Type I TARP).
Neuron
CNIH-2 and TARPs Modulate AMPA Receptorsin D-PBS plus 2%normal goat serum. Cultures were rinsed and incubated with
fluorescence-conjugated secondary antibodies (Invitrogen, 1:500) in D-PBS
for 1 hr at room temperature. After a final rinse, coverslips were mounted
and imaged using Leica immunofluorescence microscope systems (Wetzlar,
Germany).Slice Biotinylation
Rat hippocampal slices (400 mm) were incubated in slicing buffer (in mM: 124
NaCl, 26 mMNaHCO3, 3 KCl, 10 Glucose, 0.5 CaCl2, and 4MgCl2) for 1 hr. Sli-
ces were then placed into biotinylation solution (biotinylation solution = slicing
solution except [CaCl2] and [MgCl2] were raised to 2.3 and 1.3 mM, respec-
tively) 4C biotinylation solution for 5 min. Surface proteins of the dissected
were labeled with sulfo NHS SS biotin (1.5mg/mL; Pierce) for 30min on ice and
the reaction quenched with glycine (50 mM). Hippocampi were homogenized
with Tris buffer (TB: 50 mM Tris, pH 7.4, 2 mM EGTA) then sonicated. Homog-
enates were centrifuged at 100,000 3 g for 20 min and the pellet was resus-
pended in TB containing NaCl (TN: TB + 100 mM NaCl). 50% ULTRA link
Neutravidin (Roche) was added and incubated at 4C for 2 hr. Nonbound
internal protein solution was removed. Beads were washed with RIPA buffer
and biotinylated surface proteins were eluted by boiling for 5 min in Laemmli
buffer containing DTT (7.7 mg/mL). Eluted proteins and internal proteins
were separated by SDS-PAGE and detected via western blotting.Statistics
Data are represented as mean ± SEM and are the result of at least three inde-
pendent experiments. Analyses involving three or more data sets were per-
formed with a one-way ANOVA with a Tukey-Kramer post-hoc analysis using
GraphPad Prism software (Carlsbad, CA). Analyses involving two data sets
were performed with an uncorrected Student’s t test or with a Student’s
t test with a Welsh correction, only if the variances were statistically different.
Significance was set as a p-value of less than 0.05.SUPPLEMENTAL INFORMATION
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